Koen Dejonckheere. Professional experience. Board Memberships. Education

Similar documents
MENTORS REGULATORY AFFAIRS. Christophe AMIEL Head of Medical Device & Digital, Voisin Consulting Life Sciences STRATEGY/BUSINESS

Venture Capital Search Highlights

JURY BOARD BUSINESS/INVESTMENT. Pascal BECACHE Founding President, PBS, Healthcare Industry STRATEGY/BUSINESS

CFO LEADERSHIP SEMINAR DRIVING SUSTAINABLE BUSINESS MODELS PROGRAMME

Elections to the Board of Directors

WFEO STANDING COMMITTEE ON ENGINEERING FOR INNOVATIVE TECHNOLOGY (WFEO-CEIT) STRATEGIC PLAN ( )

Final Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV

Lehigh University Team biographies. October 30, 2017

Chemical industry & innovation partnerships: Impact assured!

Speaker Profile. 1 st ASBC Conference February 2019 Disruptive SBC strategies for the future of Africa

AGENDA - WESSELING ADVANCING FUTURE PLASTICS, Hotel Hilton Bonn Berliner Freiheit 2, 53111, Bonn, Germany

Binding recommendations

Expert Panel. Moderator. Global Managing Partner, Supply Chain & Operations Officers Practice. Senior Manager, Payment Solutions Operations.

The Complexities of Mixed Use

Commission proposal for Horizon Europe. #HorizonEU THE NEXT EU RESEARCH & INNOVATION PROGRAMME ( )

ANNUAL GENERAL MEETING OF ARGENX SE EXPLANATORY NOTES

Head of Private Markets. Wellershoff & Partners

1H1 / European Research Area National RTD Support Scheme for Aeronautics in France

Jan Cobbenhagen. E: W:

National Agreement on the Circular Economy. Letter of intent to develop transition agendas for the Circular Economy together

Director, Deal Advisory. At KPMG, Nicolas identifies and drives client-focused environmental/sustainability initiatives to fuel

Duncan Tait Chief Executive Officer

Universities and Sustainable Development Towards the Global Goals

IGU EXC Meeting in Muscat, Oman, on 29 March 2017, Agenda item 12. BIO BOOKLET IGU Diplomatic Gas Forum

Born Ph.D. from Karolinska Institutet in Stockholm. Board member since 2016.

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

IMCO Public Hearing. Vademecum of Speakers

Amaze AGM 2017 Non Executive Director Positions

Enhancing Audit Quality and Transparency Supplement Additional information required by Article 13 of EU Regulation 537/2014

19, av. des Camélias, 1150 Bruxelles (Belgium) Skype simbluesky

Innovative Financing for Climate Adaptation Funding Efforts to Adapt to the Impacts of Climate Change

The Dutch National Research Agenda

Forum. CEO Clubs Workshop & Forum Monday, 15 th October 2012 Hilton Athens. Keynote Speaker Dr. Srini Pillay. Rewiring Your Innovation DNA

2016 ICGN Annual General Meeting

COMMERCIAL INDUSTRY RESEARCH AND DEVELOPMENT BEST PRACTICES Richard Van Atta

Board of Directors Non Executive Directors

Enayat Qasimi. Partner. Experience M Street, NW Suite 450N Washington, DC Phone: Fax:

ANNUAL GENERAL MEETING OF SHAREHOLDERS AFFIMED N.V.

IMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters!

Ordinary and Extraordinary General Meeting. Brussels, May 24, 2012

Co C m o pa p n a y n Pr P o r f o il i e l Nove v mb m e b r r

KENYATTA UNIVERSITY. Speech

CeQur establishes Wales subsidiary

Bob McDonald. Position Held & Dates. Chairman of the Board President and Chief Executive Officer, P&G. Residence Cincinnati, Ohio, USA

ACTIVITIES JANUARY - DECEMBER, Development Technology Compliance

Visa Inc Investor Day Speaker Biographies

Our Leadership Team. Ed Peter, Chairman

Silex Systems - Board Changes

A New Platform for escience and data research into the European Ecosystem.

THE GOLDMAN SACHS GROUP, INC.

The European Platform of Universities engaged in Energy Research (EPUE) an EUA Initiative

IHH HEALTHCARE BREAKS GROUND FOR GLENEAGLES SHANGHAI AS PART OF RMB8 BILLION PUSH INTO GREATER CHINA

Sharon A. Jones, FAHP, CFRE Vice President of Development Haven Hospice Gainesville, FL

CURRICULUM VITAE. Alastair David Maclean. Senior leader with considerable commercial and change management experience

Dr Rupert Bellinghausen

Climate Change Innovation and Technology Framework 2017

1280 CENTRE STREET, SUITE 2, NEWTON CENTER, MA BAYBOSTON.COM

Mainstreaming PE in Horizon 2020: perspectives and ambitions

Research and Innovation Strategy and Action Plan UPDATE Advancing knowledge and transforming lives through education and research

Managing Risk in my career and investing in start-ups

2015 Real Estate Industry Update A landscape for change: Transforming for the future

Bob McDonald. Bob has focused P&G on winning with consumers where it matters most with products that improve their lives every day.

GLAXOSMITHKLINE CONSUMER HEALTHCARE PAKISTAN LIMITED FINANCIAL ADVISOR

An Experienced Approach to Private Equity

NORTH AUSTIN II WILKE LANE PFLUGERVILLE, TX 78660

Standard Chartered PLC Board Member Visits Ghana

CANDIDATES FOR ELECTION TO THE 2018 COUNCIL

SCIENCE, TECHNOLOGY AND INNOVATION SCIENCE, TECHNOLOGY AND INNOVATION FOR A FUTURE SOCIETY FOR A FUTURE SOCIETY

Transaction Services. Member of Invest Europe and SECA Swiss Priva te E quity & Corporate Finance Association

NIHR ROADSHOW FOR MEDTECH SMES

Finnish STI Policy

Binding Recommendations

Driving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China

Member State Programme Objec ve Focus Priori es Method Funding Source

Investment, Enterprise and Development Commission 5th session. 29 April - 3 May 2013 Geneva. Research and Innovation in Tanzania

At the forefront of Abu Dhabi s economic diversification. August 2008

Lessons Learned by Experienced CEOs of Broker-Dealers Thursday, November 12 10:15 a.m. 11:15 a.m.

Inclusion Women at the Forefront of STEM

AkzoNobel shareholders support separation of Specialty Chemicals business. New CFO and three Supervisory Board members gain shareholder approval

With a particular focus on Egypt, Indonesia, Turkey, Pakistan, and West Bank/Gaza, PNB will positively impact at least half a million lives over the

Director Phillip Bain Chief Executive Officer (CEO)

The Policy Content and Process in an SDG Context: Objectives, Instruments, Capabilities and Stages

Policy Partnership on Science, Technology and Innovation Strategic Plan ( ) (Endorsed)

The Philips Way. Page 2 of 12 About Philips

ART CONSULTANT CAREER GUIDE

THE FUTURE OF CORPORATE REPORTING Monday 16 May 2016 Great Hall, Chartered Accountants Hall, 1 Moorgate Place, EC2R 6EA, London

Mr. Smith Chairman, President, and Chief Executive Officer Southern Bank

IASB BIOGRAPHIES. BOARD MEMBERS (Participating in the IASB European Roadshows 2005)

TRANSFORMATION INTO A KNOWLEDGE-BASED ECONOMY: THE MALAYSIAN EXPERIENCE

Effective Supervision Strategies

Conclusions on the future of information and communication technologies research, innovation and infrastructures

BOARD OF DIRECTORS. PETER WEHRLY Chair

Keynote speakers 2017

David J. Adams

EVCA Institute. Finance and Administration Course November Brussels, Belgium. Private Equity Management Training

Programme Speakers Biographies Sponsors Exhibitors Media Partners Contact

YELLOW ACADEMY PROGRAMME 2019

Asia Pacific Impact Investment workshop hosted by the Global Steering Group for Impact Investment (GSG), UNESCAP and the British Council

Women on Boards of Colorado Publicly Traded Companies

The Dynamics of Change: Managing Investment Risk

Transcription:

Koen Dejonckheere Professional experience KBC SECURITIES GROUP 2002-2008 Managing Director, responsible for Corporate Finance Previously, Koen Dejonckheere was active in Corporate Finance and Private Equity GIMV NV Chief Executive Officer Gimv is a European investment company with over three decades of experience in private equity and venture capital. Gimv is listed on Euronext Brussels. Gimv currently manages around EUR 1.8 billion (including co-investment partnerships) of investments in about 50 portfolio companies. Board Memberships AZ Delta vzw (hospital Group) Home Invest SA (listed) Enternext SA Roularta NV (listed) Director of VOKA vzw and Chairman of VEV vzw Chairman Belgische Vereniging van Beursgenoteerde Bedrijven (Belgian association of listed companies) Member of the management committee of VBO-FBE Civil Engineer Material Science (University of Ghent, Belgium) Master of Business Administration (IEFSI-EDHEC, Lille-France).

Manon Janssen Major Achievements Currently, CEO & Chair of Ecorys Group. Previously, as CEO & Managing Director of Ecofys, leading a world-reknown consultancy in (sustainable) energy back to healthy growth. At Philips Lighting, led the new customer-focused outside-in mindset to drive sales, profit & market share by better understanding and meeting customers needs; established strong marketing discipline, process and capabilities. At Electrolux, established a "brand(ed) mindset", led a new brand portfolio and aligned product strategy, significantly changing the way consumers' needs are served. At Procter & Gamble, led several brands in different divisions. Established "customer marketing" as key sales accelerator in EMEA. Significantly boosted sales and profit growth on P&G's Paper division in Belgium while leading several core projects for Europe; led a major business turn-around of Health & Beauty Care in Belgium; led the set-up of the marketing department organisation for P&G's new Belgium/Holland cluster (July 1998). Previously, built P&G France's Paper business including the launch of Always. Over time, successfully developed many young managers. Professional experience ECORYS GROUP CEO and Chair of the Board of Management, Ecorys group - September 2015 -> ECOFYS GROUP- 2010-2015 CEO and Managing Director, Ecofys group ROYAL PHILIPS ELECTRONICS - 2005-2010 Chief Marketing Officer (senior vice-president), Philips Lighting Division worldwide THE ELECTROLUX COMPANY - 2001-2004 Vice-President Brands & Marketing Electrolux Home Products, Europe THE PROCTER & GAMBLE COMPANY - 1998-2001 Director Customer Marketing P&G Europe/Middle East/Africa (August 1998 - July 2001) Marketing Director Paper Division & new brands P&G Belgium (May 1996 - July 1998) Marketing Manager/Marketing Director Health & Beauty Care Division P&G Belgium (January 1993 - April 1996) Marketing Manager Paper Division P&G France (June 1990 - March 1992) Brand Manager P&G France (April 1987 - June 1990) Assistant Brand Manager P&G Benelux and P&G France (August 1984 - March 1987)

Board Memberships Chair Dutch Top Sector energy, driving the energy transition through relevant innovation programs, in cooperation with industry, knowledge institutions and society - since October 2013 Member of the advisory commission of the RLI (Dutch counsel for living environment and infrastructure), advising the Ministry of EA on the long-term energy vision for the Netherlands - 2015 Non-executive Board member at Reynaers Aluminium, Belgium - 2012-2016 Member of Green Deals Board, advising government on Green Deals with Dutch branch organizations - 2012-2013 Co-chair in the 2013 National Energy Deal led by the Socio-Economic Council - 2012 (1979-1984) Business school SOLVAY, VUB, Master of Science Business Engineering. Graduated with distinction (3d in final ranking) Challenges of Leadership, Insead 2010 Other activities and achievements 2001-2011, assistant professor at the university of Brussels, teaching marketing to MBA students In October 2004, awarded with the life-long honorary title of "Master Marketer" by the Belgian Marketing Foundation, recognizing a marketing career that further develops the agenda of marketing. One of 40 people to carry the title..

An Vermeersch Business Experience GLAXOSMITHKLINE VACCINES (WAVRE, BELGIUM) 2008 DATE 01/2016 Date Vice President, Global Health and Corporate Affairs Driving the Global Health strategy to increase access and innovation of vaccines for the developing countries Lead partnerships and engagement with Global Health stakeholders (Bill & Melinda Gates Foundation, WHO, Gavi, Unicef,...) Develop Vaccines Corporate Affairs strategy and policy for headquarter locations 2013 Date Member of Steering team of GSK Save the Children partnership Driving the immunization workstream, focusing on interventions to increase immunization coverage for children in the most difficult to reach areas 2014 2015 Vice President, Vaccines Integration Leading the Novartis Vaccines integration from planning phase up to integration implementation, with transversal team. Managing all aspects of the integration, including value capture, people and organizational restructuring, change management, communication, and the interactions with Novartis. 2011 2015 Member Vaccines Executive Team Member Vaccines Executive Team Member of Belgian Governance Board, Risk & Compliance Board, Investment Board Member of Board of Directors of GSK Biologicals 2011 2014 Vice President, Vaccines Executive Office, Strategy & Performance Responsible for strategy, business performance management, governance and the lean program Redesigned the business strategy with the executive team, and led 3-year transformation process through cross-functional teams Implemented strategy deployment and performance management approach for GSK Vaccines Built a motivated team (initially 2 growing to 70 people). Attracted diverse profiles; focused on career & development planning 2008 2011 Director Global Business Operations, Global Vaccines Development Led department of 25 people (located in US, Belgium, India), including clinical project management, strategic resourcing, operational excellence and business performance Responsible for managing global vaccines development budget Built strategic outsourcing strategy and partnership in India to outsource clinical operations Designed and delivered new organization structure and behavioral change program

Member of Global Vaccines Development leadership team McKINSEY & COMPANY, INC (BRUSSELS) 2000 2008 2006 2008 Expert Pharma R&D Led projects in pharmaceutical, vaccines and medical products industry covering product strategy, market access, sales force effectiveness and operational excellence Recognized as expert in portfolio strategy, R&D finance, clinical development excellence, R&D organization and vaccines Built view on the future of Belgian healthcare sector and healthcare reforms in Europe 2003 2006 Engagement Manager 2000 2003 Associate GLAXOSMITHKLINE BIOLOGICALS (RIXENSART, BELGIUM) 1995 2000 1998 2000 R&D Finance Business Partner 1997 1998 Global Product Manager for pediatric vaccines 1995 1997 Management Trainee Vlerick School of Management, Belgium 1995 Master of Business Administration Graduated with great distinction University of Ghent, Belgium 1994 Bio-Engineer in Microbiology and Biochemistry Research thesis at University of Burundi Graduated with great distinction Non-Executive Experience FLOREE (BELGIUM) 2016 DATE Non-executive independent board member